MarketPeel
Insider Trading Intelligence
Pricing
…
KK

Kevin Koch

EWTX
PRESIDENT AND CEO · EDGEWISE THERAPEUTICS, INC. · CIK 0001185829
FILING MIX · LIFETIME50%/50%
BUYS
19
SELLS
19
TOTAL VALUE
$1.35M
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
70,459
AVG SELL PX
$29.01
TRADE KIND
SHOWING 38 / 38
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kevin Koch, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+57.14%-3.90%+0.04%-3.94%-6.08%—
14d7+71.43%-4.97%+1.44%-6.41%-10.44%—
30d7+71.43%-9.64%-1.12%-8.51%-2.04%—
60d7+71.43%-27.19%-1.19%-26.00%-33.17%—
90d7+85.71%-22.31%+3.96%-26.26%-28.53%—
180d7+71.43%+3.51%+9.69%-6.18%-24.71%—
1y7+42.86%+58.31%+18.30%+40.01%-12.82%—
2y7(5 pending)+0.00%+74.66%+42.08%+32.57%+32.57%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 70,459 shares · as of Aug 12, 2026
0150,000300,000450,000600,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 19 buys / 19 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
21,875——70,459Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
17,969——48,584Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
21,875——65,625Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
17,969——35,938Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
8,276$43.66$361.3K53,401Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
913$44.33$40.5K52,488Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
8,782$43.64$383.3K61,677Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
87,500——87,500Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
525,000——525,000Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
7,972$13.39$106.8K30,615Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
17,968——53,907Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
17,968——38,587Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
4,276$16.45$70.4K20,619May 2, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
10,417——0May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
10,417——24,895May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$30.00$3.0K14,478Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
100$0.18$1814,578Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
100——41,545Mar 7, 2025Mar 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
900$13.11$11.8K15,378Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
900$31.13$28.0K14,478Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
900——41,645Feb 6, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
8,636——42,545Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
8,636$0.18$1.6K23,114Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,636$30.03$259.3K14,478Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
431,250——431,250Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
71,875——71,875Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
3,152$18.91$59.6K14,478May 2, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
10,417——17,630May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
10,417——10,417May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
600,000——600,000Aug 17, 2023Aug 18, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
3,203$8.90$28.5K7,213May 2, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
President and CEO
10,416——10,416May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
President and CEO
10,416——20,834May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
550,000——550,000Aug 8, 2022Aug 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,250——31,250May 1, 2022May 3, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
400,000——400,000Aug 17, 2021Aug 19, 2021 ↗View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001185829
ROLE
President and CEO
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001185829DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback